Advertisement

Critical appraisal of total thyroidectomy is more cost-effective than radioactive iodine as an alternative to antithyroid medication for Graves’ disease

Published:December 16, 2022DOI:https://doi.org/10.1016/j.surg.2022.11.019
      We have read the article “Total Thyroidectomy Is More Cost-Effective Than Radioactive Iodine as an Alternative to Antithyroid Medication for Graves’ Disease” by Ma et al, with full interest.

      Ma EZ, Kuo JH, Malek R, et al. Total thyroidectomy is more cost-effective than radioactive iodine as an alternative to antithyroid medication for Graves’ disease [e-pub ahead of print]. Surgery. https://doi.org/10.1016/j.surg.2022.06.044. Accessed xxx.

      First of all, we want to congratulate the authors for investigating a common question of an uncommon disease. We all agree that cost-effective treatment is always preferred, but at the same time safety matters most. We have some queries and comments in this regard.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. Ma EZ, Kuo JH, Malek R, et al. Total thyroidectomy is more cost-effective than radioactive iodine as an alternative to antithyroid medication for Graves’ disease [e-pub ahead of print]. Surgery. https://doi.org/10.1016/j.surg.2022.06.044. Accessed xxx.

        • Donovan P.J.
        • McLeod D.S.
        • Little R.
        • Gordon L.
        Cost-utility analysis comparing radioactive iodine, anti-thyroid drugs and total thyroidectomy for primary treatment of Graves’ disease.
        Eur J Endocrinol. 2016; 175: 595-603
        • Hughes O.R.
        • Scott-Coombes D.M.
        Hypocalcaemia following thyroidectomy for treatment of Graves’ disease: implications for patient management and cost-effectiveness.
        J Laryngol Otol. 2011; 125: 849-852
        • Ross D.S.
        • Burch H.B.
        • Cooper D.S.
        • et al.
        2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis.
        Thyroid. 2016; 26: 1343-1421